MR-guided radiofrequency ablation of hepatocellular carcinoma: Long-term effectiveness

Journal of Vascular and Interventional Radiology

Volumn 22, Issue 6, 2011, Pages 762-770

  Clasen, Stephan ^a   Rempp, Hansjörg ^a   Boss, Andreas ^a   Schmidt, Diethard ^a   Fritz, Jan ^a,b   Schraml, Christina ^a   Schick, Fritz ^a   Claussen, Claus D ^a   Pereira, Philippe L ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GELFOAM; IODINATED POPPYSEED OIL;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CANCER INFILTRATION; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; ILEOSTOMY; INTESTINE PERFORATION; LIVER CELL CARCINOMA; LIVER HEMATOMA; LUNG METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; TREATMENT OUTCOME; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; GERMANY; HUMANS; LEAST-SQUARES ANALYSIS; LINEAR MODELS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 79957558396     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.03.006     Document Type: Article

References (36)

1. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103:1201-1209. (Pubitemid 40328091)
2. Chen MH, Wei Y, Yan K, et al. Treatment strategy to optimize radio-frequency ablation for liver malignancies. J Vasc Interv Radiol 2006; 17:671-683. (Pubitemid 44392016)
3. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007; 17:684-692.
4. Takaki H, Yamakado K, Nakatsuka A, et al. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression. J Vasc Interv Radiol 2007; 18:856-861. (Pubitemid 46963611)
5. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009; 20 (Suppl):S377-S390.
6. Clasen S, Pereira PL. Magnetic resonance guidance for radiofrequency ablation of liver tumors. J Magn Reson Imaging 2008; 27:421-433. (Pubitemid 351214048)
7. Lewin JS, Connell CF, Duerk JL, et al. Interactive MRI-guided radio-frequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. J Magn Reson Imaging 1998; 8:40-47. (Pubitemid 28099557)
8. McDannold NJ, Jolesz FA. Magnetic resonance image-guided thermal ablations. Top Magn Reson Imaging 2000; 11:191-202. (Pubitemid 32208751)
9. Leyendecker JR, Dodd GD III, Halff GA, et al. Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation. AJR Am J Roentgenol 2002; 178:1147-1151. (Pubitemid 34411410)
10. Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000; 217:558-563.
11. Pacella CM, Bizzarri G, Anelli V, et al. Evaluation of the vascular pattern of hepatocellular carcinoma with dynamic computed tomography and its use in identifying optimal temporal windows for helical computed tomography. Eur Radiol 1998; 8:30-35. (Pubitemid 128545028)
12. Merkle EM, Boll DT, Boaz T, et al. MRI-guided radiofrequency thermal ablation of implanted VX2 liver tumors in a rabbit model: demonstration of feasibility at 0.2 T. Magn Reson Med 1999; 42:141-149. (Pubitemid 29325623)
13. Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 2002; 223:255-262. (Pubitemid 34258217)
14. Kettenbach J, Köstler W, Rücklinger E, et al. Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. AJR Am J Roentgenol 2003; 180:1537-1545. (Pubitemid 36687081)
15. Clasen S, Boss A, Schmidt D, et al. MR-guided radiofrequency ablation in a 0.2-T open MR system: technical success and technique effectiveness in 100 liver tumors. J Magn Reson Imaging 2007; 26:1043-1052. (Pubitemid 47548166)
16. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. American Association for the Study of Liver Diseases. Available at: http://www.aasld.org/practiceguidelines/Documents/Bookmarked%- 20Practice%20Guidelines/HCCUpdate2010.pdf. 2010; 1-35.
17. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234:961-967. (Pubitemid 40250844)
18. Aube C, Schmidt D, Brieger J, et al. Magnetic resonance imaging characteristics of six radiofrequency electrodes in a phantom study. J Vasc Interv Radiol 2004:15:385-392. (Pubitemid 38451983)
19. Kelekis AD, Terraz S, Roggan A, et al. Percutaneous treatment of liver tumors with an adapted probe for cooled-tip, impedance-controlled radio-frequency ablation under open-magnet MR guidance: initial results. Eur Radiol 2003; 13:1100-1105. (Pubitemid 36790605)
20. Mahnken AH, Buecker A, Spuentrup E, et al. MR-guided radiofrequency ablation of hepatic malignancies at 1.5 T: initial results. J Magn Reson Imaging 2004; 19:342-348. (Pubitemid 38294775)
21. Graham SJ, Bronskill MJ, Henkelman RM. Time and temperature dependence of MR parameters during thermal coagulation of ex vivo rabbit muscle. Magn Reson Med 1998; 39:198-203. (Pubitemid 28099137)
22. Lee JD, Lee JM, Kim SW, Kim CS, Mun WS. MR imaging-histopathologic correlation of radiofrequency thermal ablation lesion in a rabbit liver model: observation during acute and chronic stages. Korean J Radiol 2001; 2:151-158. (Pubitemid 33687587)
23. Lazebnik RS, Breen MS, Lewin JS, Wilson DL. Automatic model-based evaluation of magnetic resonance-guided radio frequency ablation lesions with histological correlation. J Magn Reson Imaging 2004; 19:245-254. (Pubitemid 38166803)
24. Solbiati L, Goldberg SN, Ierace T, Dellanoce M, Livraghi T, Gazelle GS. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent - early experience. Radiology 1999; 211:643-649. (Pubitemid 29249457)
25. Dodd GD III, Frank MS, Aribandi M, Chopra S, Chintapalli KN. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol 2001; 177:777-782. (Pubitemid 32881650)
26. Khajanchee YS, Streeter D, Swanstrom LL, Hansen PD. A mathematical model for preoperative planning of radiofrequency ablation of hepatic tumors. Surg Endosc 2004; 18:696-701. (Pubitemid 38569125)
27. Montgomery RS, Rahal A, Dodd GD III, Leyendecker JR, Hubbard LG. Radiofrequency ablation of hepatic tumors: variability of lesion size using a single ablation device. AJR Am J Roentgenol 2004; 182:657-661. (Pubitemid 38269526)
28. Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect. AJR Am J Roentgenol 2002; 178:47-51.
29. Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001; 11:914-921. (Pubitemid 32755549)
30. Choi D, Lim HK, Kim MJ, et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 2004; 230:135-141. (Pubitemid 37549794)
31. Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003; 97:1253-1262. (Pubitemid 36237312)
32. Takahashi S, Kudo M, Chung H, et al. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 2007; 72(suppl 1):98-103. (Pubitemid 350256672)
33. Seror O, Lepetit-Coiffé M, Le Bail B, et al. Real time monitoring of radiofrequency ablation based on MR thermometry and thermal dose in the pig liver in vivo. Eur Radiol 2008; 18:408-416. (Pubitemid 351234063)
34. Zhang Q, Chung YC, Lewin JS, Duerk JL. A method for simultaneous RF ablation and MRI. J Magn Reson Imaging 1998; 8:110-114. (Pubitemid 28099567)
35. Helmberger T, Dogan S, Straub G, et al. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma. Digestion 2007; 75:104-112. (Pubitemid 47343961)
36. Yamakado K, Nakatsuka A, Ohmori S, et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol 2002; 13:1225-1232. (Pubitemid 35440314)